Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization—a correlative study with urine PCA3 and TMPRSS2-ERG
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization—a correlative study with urine PCA3 and TMPRSS2-ERG
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 27, Issue 4, Pages 609-620
Publisher
Springer Nature
Online
2013-09-27
DOI
10.1038/modpathol.2013.169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
- (2015) Kyung Park et al. NEOPLASIA
- Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
- (2013) D. W. Lin et al. CLINICAL CANCER RESEARCH
- Correlation of UrineTMPRSS2:ERGandPCA3to ERG+ and Total Prostate Cancer Burden
- (2012) Allison Young et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Antibody-Based Detection ofERGRearrangements in Prostate Core Biopsies, Including Diagnostically Challenging Cases: ERG Staining in Prostate Core Biopsies
- (2012) Scott A. Tomlins et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [-2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer
- (2012) Jean-Nicolas Cornu et al. PROSTATE
- ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies
- (2012) M Braun et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Diagnostic Utility of Novel Immunohistochemical Marker ERG in the Workup of Prostate Biopsies With “Atypical Glands Suspicious for Cancer”
- (2011) Huiying He et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
- (2011) Marco Auprich et al. EUROPEAN UROLOGY
- Common Gene Rearrangements in Prostate Cancer
- (2011) Mark A. Rubin et al. JOURNAL OF CLINICAL ONCOLOGY
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- ERG gene rearrangement status in prostate cancer detected by immunohistochemistry
- (2011) Sara Moscovita Falzarano et al. VIRCHOWS ARCHIV
- Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
- (2010) Guillaume Ploussard et al. EUROPEAN UROLOGY
- ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
- (2009) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
- (2008) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now